Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,536 | 86 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $552.93 | 31 | $0 (2024) |
| Allergan, Inc. | $245.54 | 13 | $0 (2021) |
| Ipsen Biopharmaceuticals, Inc | $204.09 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $75.04 | 5 | $0 (2020) |
| Medtronic, Inc. | $64.59 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $59.44 | 3 | $0 (2020) |
| Merz North America, Inc. | $54.91 | 4 | $0 (2018) |
| TRICE MEDICAL, INC. | $37.31 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $33.83 | 2 | $0 (2020) |
| Amgen Inc. | $32.18 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.67 | 18 | ABBVIE INC. ($270.25) |
| 2023 | $377.53 | 21 | AbbVie Inc. ($224.09) |
| 2022 | $96.21 | 5 | ABBVIE INC. ($58.59) |
| 2021 | $19.19 | 1 | Allergan, Inc. ($19.19) |
| 2020 | $178.90 | 7 | Allergan, Inc. ($94.58) |
| 2019 | $156.36 | 11 | Allergan Inc. ($64.92) |
| 2018 | $332.89 | 23 | Allergan Inc. ($66.85) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2018 | Saol Therapeutics Inc. | Lioresal Intrathecal (baclofen injection) (Drug), Dysport | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Severe Spasticity | ||||||
| 08/09/2018 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/18/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/14/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neuroscience | ||||||
| 05/24/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 05/23/2018 | Collegium Pharmaceutical, Inc. | XTAMPZAER (Drug) | Food and Beverage | Cash or cash equivalent | $11.24 | General |
| Category: Opioid Analgesic | ||||||
| 05/03/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/28/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: MUSCULOSKELETAL | ||||||
| 01/25/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/24/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 449 | 940 | $261,450 | $68,919 |
| 2022 | 8 | 487 | 1,051 | $296,665 | $74,818 |
| 2021 | 7 | 441 | 989 | $277,810 | $72,652 |
| 2020 | 8 | 409 | 1,025 | $287,825 | $73,709 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 530 | $127,200 | $33,571 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 154 | $28,490 | $9,966 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $33,915 | $7,032 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 55 | $25,300 | $5,633 | 22.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 45 | 45 | $16,875 | $4,086 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 34 | $9,350 | $2,966 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $7,700 | $2,365 | 30.7% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 19 | 32 | $8,000 | $1,836 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,620 | $1,465 | 31.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 131 | 584 | $140,160 | $33,615 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 171 | $31,635 | $10,906 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 61 | 61 | $40,565 | $9,699 | 23.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 83 | 83 | $38,180 | $8,864 | 23.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 53 | 53 | $19,875 | $4,504 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 29 | $7,975 | $2,699 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $8,525 | $2,419 | 28.4% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2022 | 17 | 39 | $9,750 | $2,112 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 152 | 619 | $148,560 | $37,079 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 145 | $26,825 | $9,565 | 35.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 56 | 57 | $37,905 | $9,548 | 25.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 71 | 72 | $33,120 | $8,194 | 24.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 49 | 50 | $18,750 | $4,378 | 23.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $6,875 | $2,253 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $5,775 | $1,637 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 134 | 709 | $170,160 | $43,338 | 25.5% |
About Dr. Stephen Bloom, D.O
Dr. Stephen Bloom, D.O is a Physical Medicine & Rehabilitation healthcare provider based in Ypsilanti, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912940412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Bloom, D.O has received a total of $1,536 in payments from pharmaceutical and medical device companies, with $374.67 received in 2024. These payments were reported across 86 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,536).
As a Medicare-enrolled provider, Bloom has provided services to 1,786 Medicare beneficiaries, totaling 4,005 services with total Medicare billing of $290,099. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Ypsilanti, MI
- Active Since 06/13/2006
- Last Updated 06/30/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1912940412
Products in Payments
- BOTOX (Biological) $560.83
- Dysport (Drug) $136.27
- QULIPTA (Drug) $101.76
- UBRELVY (Drug) $69.03
- DYSPORT (Drug) $67.82
- BOTOX THERAPEUTIC (Biological) $66.85
- SYNCHROMEDII (Device) $64.59
- SYNCHROMED (Device) $59.44
- XEOMIN (Biological) $54.91
- AIMOVIG (Biological) $54.30
- XARELTO (Drug) $33.83
- Aimovig (Biological) $32.18
- Lioresal Intrathecal (baclofen injection) (Drug) $30.62
- EMGALITY (Drug) $25.77
- Zilretta (Drug) $24.70
- GABLOFEN (Drug) $19.69
- GENERAL PAIN MANAGEMENT (Device) $15.44
- (5044) MCOT (Device) $12.74
- LYRICA (Drug) $11.37
- XTAMPZAER (Drug) $11.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Ypsilanti
Dr. Jennifer Doble, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $17,442
Ari Kriswari, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,790
Dr. Marc Strickler, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,063
Dr. Jon Wardner, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,918
Ann Pattock, Pa-C, PA-C
Physical Medicine & Rehabilitation — Payments: $1,541
Holly Pierson, Np, NP
Physical Medicine & Rehabilitation — Payments: $1,379